For the first time in its 16-year analysis of the pharma industry, Deloitte found obesity drugs are the largest contributor to late-stage pipeline value, overtaking longtime leader oncology.
For the first time in its 16-year analysis of the pharma industry, Deloitte found obesity drugs are the largest contributor to late-stage pipeline value, overtaking longtime leader oncology.
Iran cautioned Monday it would not allow any movement through the Strait of Hormuz, hours after President Trump on Sunday said the U.S. will assist in …
President Trump on Monday afternoon is expected to participate in a small business summit at the White House. It comes one day after he said that …
A federal appeals court ruling restricts telemedicine access to the abortion drug mifepristone for the whole country, at least temporarily. But another drug that remains available …
A Massachusetts regulator is warning that CVS and Mass General Brigham’s proposed MinuteClinic partnership could drive up healthcare spending by at least $40 million annually, largely …